U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Povetacicept
INN  
Official Name English
povetacicept [INN]
Common Name English
ALPN-303 (DUAL BAFF/APRIL Fc Fusion Antagonist)
Common Name English
68-110-Tumor necrosis factor receptor superfamily protein TNFRSF13B [77-glutamic acid,78-tyrosine,102-aspartic acid] (human) fusion with peptide linker (GSGGGGS) fusion with immunoglobulin G1 [5-serine,19-alanine,20-glutamic acid,22-alanine,de-C-terminal
Common Name English
ALPN-303
Code English
Code System Code Type Description
INN
12264
Created by admin on Sat Dec 16 19:19:49 GMT 2023 , Edited by admin on Sat Dec 16 19:19:49 GMT 2023
PRIMARY
CAS
2490217-42-8
Created by admin on Sat Dec 16 19:19:49 GMT 2023 , Edited by admin on Sat Dec 16 19:19:49 GMT 2023
PRIMARY
NCI_THESAURUS
C190436
Created by admin on Sat Dec 16 19:19:49 GMT 2023 , Edited by admin on Sat Dec 16 19:19:49 GMT 2023
PRIMARY
FDA UNII
EN2U82XV65
Created by admin on Sat Dec 16 19:19:49 GMT 2023 , Edited by admin on Sat Dec 16 19:19:49 GMT 2023
PRIMARY
ACTIVE MOIETY
Povetacicept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966